This book investigates the current state of diagnosis and treatment for neuroendocrine tumors affecting the gastroenteropancreatic system, distinguishing between hereditary and sporadic forms. It synthesizes recent advancements in understanding the genetic underpinnings and clinical management of these complex conditions. The work draws upon a range of medical research, clinical trials, and expert consensus to present a comprehensive overview for medical professionals. The primary argument focuses on the evolving landscape of personalized medicine in treating these rare tumors.

This publication is recognized as a significant contribution to the field of neuroendocrine tumor research, offering a detailed examination of both hereditary and sporadic forms. It is primarily aimed at medical specialists, researchers, and advanced students in oncology and gastroenterology. The book is valued for its synthesis of complex diagnostic and treatment information, providing a crucial reference for understanding the latest developments in this specialized area of medicine.